Paeds Vivas · gastroenterology-hepatology-and-nutrition
Peptic disease and Helicobacter pylori — viva
Branching structured oral on peptic disease and H. pylori in children.
On this page & tools
Target exams
Opening (must-hit)
"In a child with dyspepsia and an alarm feature such as melaena, I investigate with upper endoscopy and biopsy rather than a non-invasive test-and-treat strategy. I only treat H. pylori if it is found endoscopically and disease is present, and I tailor eradication to susceptibility for 14 days, then confirm cure at least four weeks later off the proton-pump inhibitor." [1] [5]
Branch A — Why endoscopy, not a breath test
Examiner: Why not just do a stool antigen test and treat if positive? Candidate: In children the guidelines explicitly reject non-invasive test-and-treat. Most infected children never ulcerate, so a positive non-invasive test does not prove causation. Endoscopy confirms the ulcer, confirms the organism, and gives me tissue for susceptibility testing. [1] [2]
Branch B — Confirming the organism
Examiner: How do you make a confident endoscopic diagnosis of H. pylori? Candidate: I need more than one positive test: a positive culture, or positive histology plus a positive rapid urease test. I biopsy antrum and corpus and send tissue for culture and susceptibility. This avoids treating on a single false-positive. [1]
Branch C — Choosing eradication
Examiner: The strain is clarithromycin-resistant. What regimen? Candidate: I use a susceptibility-guided regimen for 14 days. With clarithromycin resistance I favour bismuth-based quadruple therapy at weight-appropriate paediatric doses, following local dosing tables. Susceptibility-guided treatment outperforms empiric therapy. [5] [6]
Branch D — Confirming cure
Examiner: When and how do you check it worked? Candidate: A urea breath test or monoclonal stool antigen test, at least four weeks after antibiotics and after stopping the proton-pump inhibitor for two weeks, so I do not get a false-negative from suppressed organisms. I do not use serology. [1] [8]
Branch E — The bleeding child
Examiner: He arrives with fresh haematemesis and a heart rate of 140. What now? Candidate: This is an emergency. Airway, breathing, circulation first: large-bore access, crossmatch, fluid and blood guided by perfusion and haemoglobin, and intravenous acid suppression. I arrange urgent endoscopy for diagnosis and haemostasis and involve surgery early. H. pylori status waits. [11] [1]
Branch F — The functional mimic
Examiner: A different 12-year-old has periumbilical pain, normal growth, and no alarm features. Same approach? Candidate: No. That picture fits a functional abdominal pain disorder. I make a positive Rome-based diagnosis, explain the biopsychosocial model, and avoid endoscopy and antibiotics unless alarm features appear. [2] [1]
Branch G — Treatment failure
Examiner: You confirm eradication failed. What next? Candidate: I repeat endoscopy with fresh culture and susceptibility testing, choose a tailored second-line regimen from those results, and reinforce adherence. I avoid empirically cycling antibiotics, which breeds resistance. [5] [1]
References
- [1]Homan M Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023). J Pediatr Gastroenterol Nutr, 2024.PMID 39148213
- [2]Jones NL Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr, 2017.PMID 28541262
- [5]Chan C Antimicrobial susceptibility-guided treatment is superior to empiric therapy for Helicobacter pylori infection in children. J Pediatr Gastroenterol Nutr, 2025.PMID 40778419
- [6]Vécsei A Helicobacter pylori eradication rates in children upon susceptibility testing based on noninvasive stool polymerase chain reaction versus gastric tissue culture. J Pediatr Gastroenterol Nutr, 2011.PMID 21694538
- [8]Malfertheiner P Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut, 2022.PMID 35944925
- [11]Xu QC Advances in standardized diagnosis and management of pediatric gastrointestinal bleeding. World J Pediatr, 2025.PMID 41045337